126 related articles for article (PubMed ID: 9222384)
1. Protective effects of interferon-gamma in intraocular herpes simplex type 1 infection do not depend on major histocompatibility complex class I or class II expression.
Geiger KD; Lee MS; Baugh C; Sarvetnick NE
J Neurovirol; 1995 Dec; 1(5-6):405-9. PubMed ID: 9222384
[TBL] [Abstract][Full Text] [Related]
2. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
3. Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.
Geiger K; Howes EL; Sarvetnick N
J Virol; 1994 Sep; 68(9):5556-67. PubMed ID: 8057437
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
Xiang J; Moyana T
Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.
Rajasagi NK; Kassim SH; Kollias CM; Zhao X; Chervenak R; Jennings SR
J Virol; 2009 May; 83(10):5256-68. PubMed ID: 19279095
[TBL] [Abstract][Full Text] [Related]
6. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response.
Lewandowski GA; Lo D; Bloom FE
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):2005-9. PubMed ID: 8095338
[TBL] [Abstract][Full Text] [Related]
7. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
Mikloska Z; Kesson AM; Penfold ME; Cunningham AL
J Infect Dis; 1996 Jan; 173(1):7-17. PubMed ID: 8537685
[TBL] [Abstract][Full Text] [Related]
9. Ocular production of interferon-gamma and lack of major histocompatibility complex molecules induce immunological changes in the intraocular environment.
Geiger KD; Sarvetnick NE
Ger J Ophthalmol; 1996 Nov; 5(6):309-14. PubMed ID: 9479510
[TBL] [Abstract][Full Text] [Related]
10. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.
Holterman AX; Rogers K; Edelmann K; Koelle DM; Corey L; Wilson CB
J Virol; 1999 Mar; 73(3):2058-63. PubMed ID: 9971787
[TBL] [Abstract][Full Text] [Related]
11. Spread of HSV-1 to the suprachiasmatic nuclei and retina in T cell depleted BALB/c mice.
Matsubara S; Atherton SS
J Neuroimmunol; 1997 Dec; 80(1-2):165-71. PubMed ID: 9413273
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus-1 infects the olfactory bulb shortly following ocular infection and exhibits a long-term inflammatory profile in the form of effector and HSV-1-specific T cells.
Menendez CM; Carr DJJ
J Neuroinflammation; 2017 Jun; 14(1):124. PubMed ID: 28645309
[TBL] [Abstract][Full Text] [Related]
13. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.
Heise MT; Virgin HW
J Virol; 1995 Feb; 69(2):904-9. PubMed ID: 7815559
[TBL] [Abstract][Full Text] [Related]
14. Cell surface expression of MHC molecules in glioma cells infected with herpes simplex virus type-1.
Song GY; DeJong G; Jia W
J Neuroimmunol; 1999 Jan; 93(1-2):1-7. PubMed ID: 10378863
[TBL] [Abstract][Full Text] [Related]
15. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloska Z; Cunningham AL
J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
[TBL] [Abstract][Full Text] [Related]
17. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
18. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
Ghiasi H; Perng G; Nesburn AB; Wechsler SL
Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
[TBL] [Abstract][Full Text] [Related]
19. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1.
Ghiasi H; Cai S; Nesburn AB; Wechsler SL
Curr Eye Res; 1997 Nov; 16(11):1152-8. PubMed ID: 9395776
[TBL] [Abstract][Full Text] [Related]
20. Increasing antigen presentation on HSV-1-infected cells increases lesion size but does not alter neural infection or latency.
Russell TA; Velusamy T; Tseng YY; Tscharke DC
J Gen Virol; 2018 May; 99(5):682-692. PubMed ID: 29620508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
